Isolation of Novel Peptides, Cabin-1, -2, -3, and -4, That Inhibit Cathepsin B from a Thermolysin Digest Human Plasma
-
- Nakagomi Kazuya
- Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University Faculty of Pharmaceutical Sciences, Teikyo University
-
- Fujimura Akiyoshi
- Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
-
- Maeda Hiromi
- Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
-
- Sadakane Yutaka
- Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
-
- Fujii Noriko
- Research Reactor Institute, Kyoto University
-
- Akizawa Toshifumi
- Faculty of Pharmaceutical Sciences, Setsunan University
-
- Tanimura Takenori
- Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
-
- Hatanaka Yasumaru
- Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
書誌事項
- タイトル別名
-
- Isolation of Novel Peptides, Cabin-1, -2, -3, and -4, That Inhibit Cathepsin B from a Thermolysin Digest of Human Plasma.
この論文をさがす
説明
Four novel peptides that inhibit cathepsin B, designated as Cabin-1, -2, -3, and -4, were isolated from a thermolysin digest of human plasma. After gel filtration and cation-exchange chromatography, the peptide mixture was purified by reverse-phase HPLC to isolate Cabin-1, -2, -3, and 4, with the amino acid sequences LGPVTQE, VLQSSGLYS, VVSVLT, and LVYDAY, respectively. These peptides correspond to f(64—70) of human apolipoprotein A-I for Cabin-1, f(56—64) and f(185—190) of the human immunoglobulin G γ chain for Cabin-2 and -3, and f(66—71) of human transferrin for Cabin-4. Synthetic Cabin-1, -2, -3, and -4 showed dose-dependent inhibition of cathepsin B. Their IC50 values were 450, 500, 20, and 5.0 μmol/l, respectively. Lineweaver–Burk plots suggested that Cabin-3 is a noncompetitive inhibitor, while Cabin-4 is a competitive inhibitor. Among the N- and C-terminal deletion peptides of Cabin-2 and -4, Cabin-2(1—8), VLQSSGLY, was found to have the most potent inhibitory activity, with an IC50 of 3.8 μmol/l.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 25 (5), 564-568, 2002
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204627796352
-
- NII論文ID
- 110003638715
-
- NII書誌ID
- AA10885497
-
- COI
- 1:CAS:528:DC%2BD38Xkslyrtbw%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 6154894
-
- PubMed
- 12033493
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可